Radiation therapy after thyroid surgery for high-risk cancer
Part of Cancer, Hormones & metabolism clinical trials.
This trial is testing whether giving radiation therapy after thyroid surgery can help destroy any leftover cancer cells in people with high-risk differentiated thyroid cancer. It is for those who had surgery but some cancer was still left behind.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 14 to 79 years old.
- You have been diagnosed with differentiated thyroid cancer (the most common type).
- You had surgery to remove all or nearly all of your thyroid, but some cancer cells were left behind (called R1 or R2 resection).
- You have not had radiation therapy to your head or neck before.
- You have not had radioactive iodine (I-131) treatment before.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at whether adding radiation therapy after surgery can help people with thyroid cancer that is at high risk of coming back. It includes different types of thyroid cancer, like differentiated and medullary types.
This study is comparing two different ways of giving radiation therapy for anaplastic and poorly differentiated thyroid cancer. The goal is to see which method is more effective in treating the cancer.
This trial tests how much radiation a specialized whole-body PET/CT scan delivers in patients with differentiated thyroid cancer. It may help doctors better plan treatment for cancer that persists, returns, or has spread—especially when radioactive iodine (RAI) may or may not work.
This study compares two approaches after thyroid surgery: giving radioactive iodine right away versus deciding based on follow-up test results. It aims to see which approach better helps people with intermediate-risk differentiated thyroid cancer.
This study looks at how well radioactive iodine therapy works for patients with certain types of thyroid cancer that are considered low or intermediate risk. It may help you understand if this treatment is right for you.
This trial is testing whether thyroid hormone replacement after surgery is safe for people with low-risk papillary thyroid cancer. It may help maintain normal hormone levels after part of the thyroid is removed.
Hear when a new Thyroid Cancer trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.